A Comparative Analysis of Public Policies on Vaccination

METE YILDIZ

doi:10.17065/HUNIIBF.1099139

Outline

A Comparative Analysis of Public Policies on Vaccination

METE YILDIZ

2023, Hacettepe Üniversitesi İktisadi ve İdari Bilimler Fakültesi dergisi

https://doi.org/10.17065/HUNIIBF.1099139

visibility

…

description

23 pages

link

1 file

Abstract

Halk sağlığı açısından acil durumlara sebep olan bulaşıcı hastalık salgını gibi felaketler hem milyonlarca insanın ölümüne hem de sosyal, politik ve ekonomik sistemlerin dengesinin bozulmasına neden olabilmektedir. Bu duruma en güncel örnek COVID-19 salgınıdır. Bu sebeple çalışma, kamu politikası uygulama örneği olarak COVID-19 salgını başta olmak üzere çeşitli salgınları ve aşı ile önlenebilir hastalıkları kontrol altına almaya yönelik geliştirilen kitlesel aşı politikalarının tasarım ve uygulama aşamalarını incelemiştir. Genel olarak tıp alanının inceleme konusu olan aşılama politikalarına kamu politikası açısından bir bakış sunularak bu politikaların çok-disiplinli bir bakış açısıyla ele alınması hedeflenmiştir. Bu doğrultuda özellikle aşılama politikalarını başarısız kılan etkenler hakkındaki ikincil veriler toplanmış ve bu veriler ışığında, gelecekteki aşılama politikalarının daha etkin yürütülmesine katkı sağlayabileceği düşünülen birtakım öneriler sunulmuştur. Bu öneriler; 1- Aşı kampanyalarına daha fazla önem verilmesi, 2- Karar verme süreçlerinin geliştirilmesi ve hızlandırılması, 3- Şeffaflığın ön planda tutulması, 4- Dengeli aşılama politikaları oluşturulması, 5- Yeni teknolojilere yeterli bütçe ayrılması, 6- Aşı uygulamalarında denetimlerin artırılması, 7- Halkın güveninin kazanılması, 8- Sağlık çalışanları ve diğer paydaşlar ile iş birliği yapılması, 9- Ebeveynlere ve bakıcılara özel eğitimler düzenlenmesi, 10- Bilgi eksikliği ile mücadele edilmesi, 11- Kitle iletişim araçlarının doğru ve etkin kullanılması, olarak özetlenebilir.

References (43)

Baden, L., El Sahly, H., Essink, B., Doblecki-Lewis, S., Martin, J., Anderson, E., Campbell, T. B., Clark, J., Jackson, L., Fichtenbaum, C., Zervos, M., Rankin, B., Eder, F., Feldman, G., Kennelly, C., Han-Conrad, L., Levin, M., Neuzil, K., Corey, L., Gilbert, P., Janes, H., Follmann, D., Marovich, M., Polakowski, L., Mascola, J., Ledgerwood, J., Graham, B., August, A., Clouting, H., Deng, W., Han, S., Leav, B., Manzo, D., Pajon, R., Schödel, F., Tomassini, J., Zhou, H. & Miller, J. (2021). Efficacy of the mRNA-1273 SARS-Cov-2 vaccine at completion of blinded phase. New England Journal of Medicine, 385(19), 1774-1785. https://doi.org//10.1056/NEJMoa2113017
Baekkeskov, E. (2016). Same threat, different responses: Experts steering politicians and stakeholders in 2009 H1N1 vaccination policy-making. Public Administration, 94(2), 299- 315. https://doi.org/10.1111/padm.12244
Baekkeskov, E. & Rubin O. (2014). Why pandemic response is unique: Powerful experts and hands-off political leaders. Disaster Prevention and Management, 23(1), 81-93. https://doi.org/10.1108/DPM-05-2012-0060
Bernard, N. R., Basit, A., Sofija, E., Phung, H., Lee, J., Rutherford, S., Sebar, B., Harris, N., Phung, D. & Wiseman, N. (2021). Analysis of crisis communication by the prime minister of australia during. Journal of Disaster Risk Reduction, 62, 102375. https://doi.org/10.1016/j.ijdrr.2021.102375
Birkland, T. A. (2010). An ıntroduction to the policy process: theories, concepts, and models of public policy making. New York: M. E. Sharpe.
Bryson, M., Duclos, P., Jolly, A. & Çakmak, N. (2010). A global look at national immunization technical advisory groups. Vaccine, 28, A13-A17. https://doi.org/10.1016/j.vaccine.2009.07.089
Casula, M. & Toth, F. (2021). The 2017 Italian reform on mandatory childhood vaccinations: Analysis of the policy process and early implementation. Health Policy, 125(1), 7-11. https://doi.org/10.1016/j.healthpol.2020.11.004
Chigwedere, P., Seage, G., Gruskin, S., Lee, T. & Essex (2008). Estimating the lost benefits of antiretroviral drug use in South Africa. JAIDS Journal of Acquired Immune Deficiency Syndromes, 49(4), 410-415. https://doi.org/10.1097/QAI.0b013e31818a6cd5
Galles, N., Liu, P., Updike, R., Fullman, N., Nguyen, J., Rolfe, S., vd. (2021). Measuring routine childhood vaccination coverage in 204 countries and territories, 1980-2019: A systematic analysis for the global burden of disease study 2020, Release 1. The Lancet, 398(10299),503-521. https://doi.org/10.1016/S0140-6736(21)00984-3
Greenwood, M. & Yule, U. (1915). The statistics of anti-typhoid and anti-cholera inoculations, and the interpretation of such statistics in general. https://doi/pdf/10.1177/003591571500801433
Henley, J. & Roy, E. A. (2020). Are female leaders more successful at managing the Coronavirus Crisis. The Guardian, 25. 10 Haziran 2022 tarihinde https://www.theguardian.com/world/2020/apr/25/why-do-female-leaders-seem-to- be-more-successful-at-managing-the-coronavirus-crisis adresten erişilmiştir.
Ho, L., Gurung, S., Mirza, I., Nicolas, H. D., Steulet, C., Burman, A., Danovaro-Holliday, C., Sodha, S. & Kretsinger, K. (2021). Impact of the SARS-CoV-2 pandemic on vaccine preventable disease campaigns. 5 Nisan 2022 tarihinde https://ssrn.com/abstract=3963780 adresten erişilmiştir.
Jung, J. (2021). Preparing for the coronavirus disease (COVID-19) vaccination: Evidence, plans, and implications. Journal of Korean Medical Science, 36(7), e59. https://doi.org/10.3346/jkms.2021.36.e59
Karmaker, C. L., Ahmed, T., Ahmed, S., Mithun, S., Moktadir, A. & Kabir, G. (2021). Improving supply chain sustainability in the context of COVID-19 pandemic in an emerging economy: Exploring drivers using an integrated model. Sustainable Production and Consumption, 26, 411-427. https://doi.org/10.1016/j.spc.2020.09.019
Larson, H. J., Figueiredo, A., Xiahong, Z., Schulz, W., Verger, P., Johnston, L., Cook, A. & Jones, N. (2016). The state of vaccine confidence 2016: Global insights through a 67-country survey. Ebiomedicine, 12, 295-301. https://doi.org/10.1016/j.ebiom.2016.08.042
Lazarus, J. V., Ratzan, S. C., Palayew, A., Gostin, L. O., Larson, H. J., Rabin, K., Kimball, S. & El- Mohandes, A. (2021). A global survey of potential acceptance of a COVID-19 vaccine. Nature Medicine, 27(2), 225-228. https://doi.org/10.1038/s41591-020-1124-9
MacDonald, N. E. (2015). Vaccine hesitancy: Definition, scope and determinants. Vaccine, 33(34), 4161-4164. https://doi.org/10.1016/j.vaccine.2015.04.036
Maitlis, S. & Christianson, M. (2014). Sensemaking in organizations: Taking stock and moving forward. Academy of Management Annals, 8(1), 57-125. https://doi.org/10.5465/19416520.2014.873177
Manupati, V. K., Schoenherr, T., Subramanian, N., Ramkumar, M., Soni, B. & Panigrahi, S. (2021). A multi-echelon dynamic cold chain for managing vaccine distribution. Transportation Research Part E: Logistics and Transportation Review, 156, 102542. https://doi.org/10.1016/j.tre.2021.102542
Mathieu, E. (2021). Which countries are on track to reach global COVID-19 vaccination targets?. 10 Nisan 2022 tarihinde https://ourworldindata.org/covid-vaccination-global- projections adresten erişilmiştir.
Medeiros, K. E., Crayne, M. P., Griffith, J. A., Hardy III, J. H. & Damadzic, A. (2022). Leader sensemaking in response to crisis: Consequences and insights from the COVID-19 pandemic. Personality and Individual Differences, 187, 111406. https://doi.org/10.1016/j.paid.2021.111406
Navin, M. C., Kozak, A. T. & Attwell, K. (2021). School staff immunization governance: Missed opportunities for public health promotion. Vaccine, 40(51), 7433-7439. https://doi.org/10.1016/j.vaccine.2021.07.061
Neufeind, J., Betsch, C., Habersaat, K. B., Eckardt, M., Schmid, P. & Wichmann, O. (2020). Barriers and drivers to adult vaccination among family physicians-insights for tailoring the immunization program in Germany. Vaccine, 38(27), 4252-4262. https://doi.org/10.1016/j.vaccine.2020.04.052
Nohynek, H., Wichmann, O., D'Ancona, F. & Gatekeepers, V. N. (2013). National advisory groups and their role in immunization policy-making processes in European countries. Clinical Microbiology and Infection, 19(12), 1096-1105. https://doi.org/10.1111/1469- 0691.12315
Onyemelukwe, C. (2016). Can legislation mandating vaccination solve the challenges of routine childhood immunisation in Nigeria?. Oxford University Commonwealth Law Journal, 16(1), 100-124. https://doi.org/10.1080/14729342.2016.1244450
Orhan, G. & Yalçın, L. (2015). Ağlar, yönetişim ve ağ yönetişimi: Tarihsel ve kavramsal bir değerlendirme'', Köseoğlu, Ö. & Sobacı, M. Z. (Der.), Kamu Yönetiminde Paradigma Arayışları: Yeni Kamu İşletmeciliği ve Ötesi. Bursa: Dora yayınları. 171-204.
Our World in Data. (2019). Vaccination. 12 Aralık 2021 tarihinde https://ourworldindata.org/vaccination adresten erişilmiştir.
Piso, B. & Wild, C. (2009). Decision support in vaccination policies. Vaccine, 27(43), 5923-5928. https://doi.org/10.1016/j.vaccine.2009.07.105
Plotkin, S., Robinson, J., Cunninghamc, G., Iqbald, R. & Larsen, S. (2017). The complexity and cost of vaccine manufacturing-an overview. Vaccine, 35(33), 4064-4071. https://doi.org/10.1016/j.vaccine.2017.06.003
Polack, F., Thomas, S., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J., Marc, G., Moreira, E., Zerbini, C., Bailey, R., Swanson, K., Roychoudhury, S., Koury, K., Li, P., Kalina, W., Cooper, D., Frenck, R., Hammitt, L., Türeci, Ö., Nell, H., Schaefer, A., Ünal, S., Tresnan, D., Mather, S., Dormitzer, P., Şahin, U., Jansen, K. & Gruber, W. (2020). Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. New England Journal of Medicine, 383, 2603-2615. https://doi.org/10.1056/NEJMoa2034577
Qiu, J., Hu, H., Zhou, S., & Liu, Q. (2016). Vaccine scandal and crisis in public confidence in China. The Lancet, 387(10036), 2382. https://doi.org/10.1016/S0140-6736(16)30737-1
Rainey, J., Watkinsa, M., Rymana, T., Sandhua, P., Boa, A. & Banerjeeb, K. (2011). Reasons related to non-vaccination and under-vaccination of children in low and middle income countries: Findings from a systematic review of the published literature, 1999-2009.
Vaccine, 29(46), 8215-8221. https://doi.org/10.1016/j.vaccine.2011.08.096
Rappuoli, R. & Hanon, E. (2018). Sustainable vaccine development: A vaccine manufacturer's perspective. Current Opinion in Immunology, 53, 111-118. https://doi.org/10.1016/j.coi.2018.04.019
Rhodes, N., Wright, T., Rusu, V., Bakhtari, H., Cushing, J. & Kohler, J. (2021). For whose benefit? transparency in the development and procurement of COVID-19 vaccines. 1 Aralık 2021 tarihinde https://transparency.org.uk/sites/default/files/pdf/publications/For%20Whose%20Be nefit%20-%20Transparency%20International.pdf adresten erişilmiştir.
Siddiqi, S., Masud, T., Nishtar, S., Peters, D., Sabri, P., Bile, K. & Jama, M. A. (2009). Framework for assessing governance of the health system in developing countries: Gateway to good governance. Health Policy, 90(1), 13-25. https://doi.org/10.1016/j.healthpol.2008.08.005
Silva, M. L., Perrier, L., Cohen, J. M., Paget, W., Mosnier, A. & Späth, H. M. (2015). A literature review to identify factors that determine policies for influenza vaccination. Health Policy, 119(6), 697-708. https://doi.org/10.1016/j.healthpol.2015.04.006
Steffen, C., Henaffa, L., Durupta, A., El Omeiri, N., Ndiaye, S., Batmunkh, N., Liyanage, J., Hasan, Q., Mosina, L., Jones, I., O'Brien, K. & Hombach, J. (2021). Evidence-informed vaccination decision-making in countries: Progress, challenges and opportunities. Vaccine, 39(15), 2146-2152. https://doi.org/10.1016/j.vaccine.2021.02.055
Tentori, K., Timberlake, B. & Pighin. S. (2021). The misunderstanding of vaccine efficacy. Social Science & Medicine, 289. https://doi.org/10.1016/j.socscimed.2021.114273
Vanderslott, S. & Marks, T. (2021). Charting mandatory childhood vaccination policies worldwide. Vaccine, 39, 4054-4062. https://doi.org/10.1016/j.vaccine.2021.04.065
Weinberg, G. & Szilagyi, P. (2010). Vaccine epidemiology: Efficacy, effectiveness, and the translational research roadmap. The Journal of Infectious Diseases, 201(11), 1607-1610. https://doi.org/10.1086/652404
World Health Organization (WHO, 2019). The global vaccine action plan 2011-2020: Review and lessons learned: strategic advisory group of experts on immunization. 16 Haziran 2021 tarihinde https://apps.who.int/iris/handle/10665/329097 adresten erişilmiştir.
Zhuang, J. L., Wagner, A., Laffoon, M., Lu, H. H. & Jiang, Q. W. (2019). Procurement of category 2 vaccines in China. Vaccines, 7(3), 1-11. https://doi.org/10.3390/vaccines7030097

A Comparative Analysis of Public Policies on Vaccination

Sign up for access to the world's latest research

Abstract

Related papers

References (43)

Related papers